NYSE:LH - Laboratory Corp. of America Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$180.76 -1.43 (-0.78 %)
(As of 08/20/2018 10:26 AM ET)
Previous Close$181.81
Today's Range$180.31 - $182.16
52-Week Range$146.68 - $190.35
Volume2,590 shs
Average Volume705,587 shs
Market Capitalization$18.30 billion
P/E Ratio18.86
Dividend YieldN/A
Beta0.98
Laboratory Corp. of America logoLaboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. It offers a range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, prostate-specific antigen, tests for sexually-transmitted diseases, hepatitis C tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. The company also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, medical drug monitoring, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, it provides drug development solutions and laboratory testing services; and testing services through a sales force to the managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories. The company has collaboration with university, hospital and academic institutions, such as Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:LH
CUSIP50540R40
Phone336-229-1127

Debt

Debt-to-Equity Ratio0.86
Current Ratio1.42
Quick Ratio1.32

Price-To-Earnings

Trailing P/E Ratio18.86
Forward P/E Ratio15.65
P/E Growth1.73

Sales & Book Value

Annual Sales$10.44 billion
Price / Sales1.76
Cash Flow$15.1390 per share
Price / Cash11.94
Book Value$67.09 per share
Price / Book2.69

Profitability

EPS (Most Recent Fiscal Year)$9.60
Net Income$1.27 billion
Net Margins11.59%
Return on Equity16.38%
Return on Assets6.64%

Miscellaneous

Employees60,000
Outstanding Shares101,900,000
Market Cap$18.30 billion

Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) issued its earnings results on Wednesday, July, 25th. The medical research company reported $2.98 EPS for the quarter, topping the consensus estimate of $2.92 by $0.06. The medical research company earned $2.87 billion during the quarter, compared to analysts' expectations of $2.85 billion. Laboratory Corp. of America had a return on equity of 16.38% and a net margin of 11.59%. Laboratory Corp. of America's quarterly revenue was up 13.4% compared to the same quarter last year. During the same period last year, the business earned $2.47 earnings per share. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Wednesday, October, 24th 2018. View Earnings Estimates for Laboratory Corp. of America.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America issued an update on its FY18 earnings guidance on Wednesday, July, 25th. The company provided EPS guidance of $11.35-11.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.57. The company issued revenue guidance of $11.47 billion, compared to the consensus revenue estimate of prior $11.30-11.70.

What price target have analysts set for LH?

16 Wall Street analysts have issued 12-month target prices for Laboratory Corp. of America's stock. Their forecasts range from $175.00 to $220.00. On average, they anticipate Laboratory Corp. of America's stock price to reach $196.5625 in the next year. This suggests a possible upside of 8.7% from the stock's current price. View Analyst Price Targets for Laboratory Corp. of America.

What is the consensus analysts' recommendation for Laboratory Corp. of America?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Laboratory Corp. of America.

Who are some of Laboratory Corp. of America's key competitors?

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • Mr. Gary M. Huff, Chief Exec. Officer of Labcorp Diagnostics (Age 51)
  • Mr. David P. King, Chairman, CEO & Pres (Age 62)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 57)
  • Dr. Michelle Abelson, Laboratory Director of Operations
  • Mr. Edward T. Dodson, Chief Accounting Officer & Sr. VP (Age 65)

Has Laboratory Corp. of America been receiving favorable news coverage?

Media headlines about LH stock have been trending somewhat positive on Monday, according to Accern Sentiment Analysis. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Laboratory Corp. of America earned a news and rumor sentiment score of 0.21 on Accern's scale. They also assigned headlines about the medical research company an impact score of 46.23 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View Recent Headlines for Laboratory Corp. of America.

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.55%), Boston Partners (5.56%), Iridian Asset Management LLC CT (1.73%), OppenheimerFunds Inc. (1.67%), Dimensional Fund Advisors LP (1.40%) and Ariel Investments LLC (1.11%). Company insiders that own Laboratory Corp. of America stock include Adam H Schechter, David P King, Dwight Gary Gilliland, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Which major investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, FMR LLC, Bank of Montreal Can, Millennium Management LLC, Sawgrass Asset Management LLC, Summit Trail Advisors LLC, Cooke & Bieler LP and Weitz Investment Management Inc.. Company insiders that have sold Laboratory Corp. of America company stock in the last year include Adam H Schechter, David P King, Dwight Gary Gilliland, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, Lisa J Uthgenannt and M Huff Gary. View Insider Buying and Selling for Laboratory Corp. of America.

Which major investors are buying Laboratory Corp. of America stock?

LH stock was bought by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Egerton Capital UK LLP, BlackRock Inc., Redmile Group LLC, Pwmco LLC, Teacher Retirement System of Texas, Wafra Inc. and California Public Employees Retirement System. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $180.76.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $18.30 billion and generates $10.44 billion in revenue each year. The medical research company earns $1.27 billion in net income (profit) each year or $9.60 on an earnings per share basis. Laboratory Corp. of America employs 60,000 workers across the globe.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (NYSE LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  388 (Vote Outperform)
Underperform Votes:  420 (Vote Underperform)
Total Votes:  808
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel